ACH logo

Accendra Health, Inc. Stock Price

NYSE:ACH Community·US$100.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

ACH Share Price Performance

US$1.20
-3.85 (-76.24%)
US$1.75
Fair Value
US$1.20
-3.85 (-76.24%)
31.4% undervalued intrinsic discount
US$1.75
Fair Value
Price US$1.20
AnalystLowTarget US$1.75
AnalystConsensusTarget US$4.49
AnalystHighTarget US$6.00

ACH Community Narratives

·
Fair Value US$1.75 31.4% undervalued intrinsic discount

Rising Healthcare Pressures Will Exacerbate Patient Direct Vulnerabilities

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$4.49 73.3% undervalued intrinsic discount

Patient Direct Model Will Transform Home-Based Health Care Market

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value US$6 80.0% undervalued intrinsic discount

Home-based Care Expansion Will Drive Secular Growth

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$1.75
31.4% undervalued intrinsic discount
Profit Margin
6.26%
Future PE
1.11x
Price in 2029
US$2.47

Trending Discussion

No trending discussion available.

Updated Narratives

ACH logo

ACH: Index Additions And CEO Succession Will Support Future Upside

Fair Value: US$1.75 31.4% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ACH logo

ACH: New Leadership And Kitting Expansion Will Support Future Stock Upside

Fair Value: US$6 80.0% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ACH logo

ACH: Raised Fair Value Assumptions Will Support 2026 Profitability Narrative

Fair Value: US$4.49 73.3% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued with slight risk.

4 Risks
3 Rewards

Accendra Health, Inc. Key Details

US$2.6b

Revenue

US$1.5b

Cost of Revenue

US$1.2b

Gross Profit

US$1.3b

Other Expenses

-US$110.6m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-1.44
44.83%
-4.18%
-311.8%
View Full Analysis

About ACH

Founded
1882
Employees
6500
CEO
Edward Pesicka
WebsiteView website
www.accendrahealth.com

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Recent ACH News & Updates

Narrative Update Aug 10

ACH: Index Additions And CEO Succession Will Support Future Upside

Analysts have reduced their fair value estimate for Accendra Health from $2.70 to $1.75, reflecting weaker revenue growth assumptions, a slightly higher discount rate, and a lower future P/E multiple, partly offset by a modestly higher projected profit margin. What’s in the News for Accendra Health Chief Executive Officer Edward A.

Recent updates

No updates